101. BPIFB1 loss alters airway mucus properties and diminishes mucociliary clearance
- Author
-
Matthew R. Markovetz, Samir N. P. Kelada, Troy D. Rogers, Lauren J. Donoghue, Camille Ehre, Barbara R. Grubb, Cameron B. Morrison, David B. Hill, Brian Button, and Kathryn M. McFadden
- Subjects
Lung ,medicine.anatomical_structure ,Secretory protein ,In vivo ,Chemistry ,Mucociliary clearance ,Mucin ,medicine ,Respiratory epithelium ,respiratory system ,Airway ,Mucus ,Cell biology - Abstract
Airway mucociliary clearance (MCC) is required for host defense and often diminished in chronic lung diseases. Effective clearance depends upon coordinated actions of the airway epithelium and a mobile mucus layer. Dysregulation of the primary secreted airway mucin proteins, MUC5B and MUC5AC, is associated with a reduction in the rate of MCC; however, how other secreted proteins impact the integrity of the mucus layer and MCC remains unclear. We previously identified the gene Bpifb1/Lplunc1 as a regulator of airway MUC5B levels using genetic approaches. Here, we show that BPIFB1 is required for normal mucociliary clearance in vivo using Bpifb1 knockout (KO) mice. Reduced MCC in Bpifb1 KO mice occurred in the absence of defects in sodium or chloride ion transport or reduced ciliary beat frequency. BPIFB1 loss resulted in airway mucus flakes with significantly increased complex viscosity, a key biophysical property of mucus known to impact MCC. Finally, we detected colocalization of BPIFB1 and MUC5B in secretory granules in mice and in the protein mesh of secreted mucus in human airway cultures. Collectively, our findings demonstrate that BPIFB1 is an important component of the mucociliary apparatus in mice and a key component of the mucus protein network.
- Published
- 2020
- Full Text
- View/download PDF